Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB01111_DB01172> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB01111_DB01172 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01111_DB01172 label "DDI between Colistimethate and Kanamycin - Aminoglycosides may enhance the nephrotoxic effect of Colistimethate. Aminoglycosides may enhance the neuromuscular-blocking effect of Colistimethate. Due to the potential for additive or synergistic toxicities (including both nephrotoxicity and neuromuscular blockade) between colistimethate and the aminoglycoside antibiotics, this combination should be avoided whenever possible. If these agents must be used together, patients' renal and neuromuscular function should be monitored closely. [drugbank_resource:DB01111_DB01172]" assertion.
- drugbank_resource:DB01111_DB01172 identifier "drugbank_resource:DB01111_DB01172" assertion.
- drugbank_resource:DB01111_DB01172 title "DDI between Colistimethate and Kanamycin - Aminoglycosides may enhance the nephrotoxic effect of Colistimethate. Aminoglycosides may enhance the neuromuscular-blocking effect of Colistimethate. Due to the potential for additive or synergistic toxicities (including both nephrotoxicity and neuromuscular blockade) between colistimethate and the aminoglycoside antibiotics, this combination should be avoided whenever possible. If these agents must be used together, patients' renal and neuromuscular function should be monitored closely." assertion.